ANVS
Annovis Bio, Inc.
$1.99
+0.07 (+3.65%)
At close · Jul 8
Market Cap
$68.95M
Shares
34,646,868
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-17 | — | |
| 8-K | 2026-05-20 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-15 | — | |
| DEF 14A | 2026-04-30 | 2026-06-17 | |
| 8-K | 2026-04-10 | 2026-04-09 | |
| 8-K | 2026-03-25 | 2026-03-23 | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-13 | 2025-12-31 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-01-28 | — | |
| 8-K | 2025-11-13 | 2025-11-12 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-28 | 2025-10-26 | |
| 8-K | 2025-10-14 | 2025-10-10 | |
| 8-K | 2025-09-29 | 2025-09-25 | |
| 8-K | 2025-08-15 | 2025-08-11 | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-23 | 2025-06-17 | |
| 8-K | 2025-06-20 | 2025-06-19 | |
| 8-K | 2025-05-13 | 2025-05-09 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-30 | 2025-06-17 | |
| 8-K | 2025-03-27 | 2025-03-26 | |
| 10-K | 2025-03-21 | 2024-12-31 | |
| 8-K | 2025-03-21 | — | |
| 8-K | 2025-02-05 | — | |
| 8-K | 2025-02-05 | 2025-02-03 | |
| 8-K | 2024-12-11 | — | |
| 8-K | 2024-12-11 | — | |
| 8-K | 2024-12-09 | 2024-12-04 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-10-15 | — | |
| 8-K | 2024-09-30 | — | |
| 8-K | 2024-08-15 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-07-16 | — | |
| 8-K | 2024-07-10 | — | |
| 8-K | 2024-07-02 | — | |
| 8-K | 2024-06-13 | — | |
| 8-K | 2024-06-11 | — | |
| 8-K | 2024-06-05 | — | |
| 8-K | 2024-05-21 | — | |
| 8-K | 2024-05-13 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| 8-K | 2024-05-06 | — |
Showing 1–50 of 112 filings